Applicant, as named in the Orange Book
Axsome Malta
Axsome Therapeutics Inc · Nasdaq: AXSM
Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings
Next listed expiry: Sunosi on 30 Dec 2042. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Sunosi NDA 211230 · 2 strengths solriamfetol hydrochloride | 30 Dec 2042 patent, carve-out possible |
Recent events
- Sunosi · Generic tentatively approved · ANDA 218761, Unichem Laboratories LtdTentative approval 29 Sep 2026Detected 25 Oct 2026
- Sunosi · Generic approved · ANDA 218725, Aurobindo Pharma LtdApproved 6 Oct 2026Detected 25 Oct 2026
- Sunosi · First generic approved · ANDA 218016, HikmaApproved 17 Jun 2026Detected 25 Oct 2026
- Sunosi · Generic approved · ANDA 218016, HikmaApproved 17 Jun 2026Detected 25 Oct 2026
- Sunosi · First generic approved · ANDA 218722, Alkem Labs LtdApproved 17 Jun 2026Detected 25 Oct 2026
- Sunosi · Generic approved · ANDA 218722, Alkem Labs LtdApproved 17 Jun 2026Detected 25 Oct 2026